Literature DB >> 20201574

Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations.

Jeffrey R Simard1, Matthäus Getlik, Christian Grütter, Ralf Schneider, Sabine Wulfert, Daniel Rauh.   

Abstract

Targeting protein kinases with small organic molecules is a promising strategy to regulate unwanted kinase activity in both chemical biology and medicinal chemistry research. Traditionally, kinase inhibitors are identified in activity-based screening assays using enzymatically active kinase preparations to measure the perturbation of substrate phosphorylation, often resulting in the enrichment of classical ATP competitive (Type I) inhibitors. However, addressing enzymatically incompetent kinase conformations offers new opportunities for targeted therapies and is moving to the forefront of kinase inhibitor research. Here we report the development of a new FLiK (Fluorescent Labels in Kinases) binding assay to detect small molecules that induce changes in the conformation of the glycine-rich loop. Due to cross-talk between the glycine-rich loop and the activation loop in kinases, this alternative labeling approach can also detect ligands that stabilize inactive kinase conformations, including slow-binding Type II and Type III kinase inhibitors. Protein X-ray crystallography validated the assay results and identified a novel DFG-out binding mode for a quinazoline-based inhibitor in p38alpha kinase. We also detected the high-affinity binding of a clinically relevant and specific VEGFR2 inhibitor, and we provide structural details of its binding mode in p38alpha, in which it stabilizes the DFG-out conformation. Last, we demonstrate the power of this new FLiK labeling strategy to detect the binding of Type I ligands that induce conformational changes in the glycine-rich loop as a means of gaining affinity for the target kinase. This approach may be a useful alternative to develop direct binding assays for kinases that do not adopt the DFG-out conformation while also avoiding the use of expensive kits, detection reagents, or radioactivity frequently employed with activity-based assays.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201574     DOI: 10.1021/ja908083e

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  13 in total

1.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

2.  Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

Authors:  Natalie B Vinh; Jamie S Simpson; Peter J Scammells; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2012-04-20       Impact factor: 3.686

3.  Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.

Authors:  Wanli You; Chia-En A Chang
Journal:  J Chem Inf Model       Date:  2018-04-16       Impact factor: 4.956

4.  FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures.

Authors:  Tobias Klein; Julie Tucker; Geoffrey A Holdgate; Richard A Norman; Alexander L Breeze
Journal:  ACS Med Chem Lett       Date:  2013-12-06       Impact factor: 4.345

5.  Discovery of a potential allosteric ligand binding site in CDK2.

Authors:  Stephane Betzi; Riazul Alam; Mathew Martin; Donna J Lubbers; Huijong Han; Sudhakar R Jakkaraj; Gunda I Georg; Ernst Schönbrunn
Journal:  ACS Chem Biol       Date:  2011-02-22       Impact factor: 5.100

6.  Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2.

Authors:  Giulio Rastelli; Andrew Anighoro; Martina Chripkova; Laura Carrassa; Massimo Broggini
Journal:  Cell Cycle       Date:  2014-06-09       Impact factor: 4.534

7.  Fluorophore labeled kinase detects ligands that bind within the MAPK insert of p38α kinase.

Authors:  Matthäus Getlik; Jeffrey R Simard; Martin Termathe; Christian Grütter; Matthias Rabiller; Willem A L van Otterlo; Daniel Rauh
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

8.  DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors.

Authors:  Zhifeng Huang; Li Tan; Huiyan Wang; Yang Liu; Steven Blais; Jingjing Deng; Thomas A Neubert; Nathanael S Gray; Xiaokun Li; Moosa Mohammadi
Journal:  ACS Chem Biol       Date:  2014-10-27       Impact factor: 5.100

Review 9.  Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?

Authors:  Zheng Zhao; Hong Wu; Li Wang; Yi Liu; Stefan Knapp; Qingsong Liu; Nathanael S Gray
Journal:  ACS Chem Biol       Date:  2014-04-29       Impact factor: 5.100

10.  Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor.

Authors:  Zhi Tan; Lu Chen; Shuxing Zhang
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.